Goldman Sachs Group Inc Clear Point Neuro, Inc. Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 286,792 shares of CLPT stock, worth $7.08 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
286,792
Previous 257,871
11.22%
Holding current value
$7.08 Million
Previous $3.07 Million
11.68%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding CLPT
# of Institutions
104Shares Held
7.91MCall Options Held
116KPut Options Held
46.8K-
Vanguard Group Inc Valley Forge, PA1.48MShares$36.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA625KShares$15.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY366KShares$9.05 Million0.0% of portfolio
-
State Street Corp Boston, MA333KShares$8.23 Million0.0% of portfolio
-
Morgan Stanley New York, NY332KShares$8.21 Million0.0% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $605M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...